Effects of a cardiac rehabilitation program based on continuous high-intensity Nordic Walking training

Effects of a phase III cardiac rehabilitation program based on continuous high-intensity Nordic Walking training: A randomised controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN81600482

Enrollment

Registered

2022-07-04

Start date

2018-10-01

Completion date

Unknown

Last updated

2022-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with stable ischemic heart disease and preserved systolic function Circulatory System

Interventions

The phase III CRP began within a maximum period of 5 days after the end of the phase II and lasted 12 months. Intervention group: a) 104 supervised sessions of 75 minutes of NW endurance training su

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Clinically stable patients with a medical diagnosis of non-ST-segment elevation acute coronary syndrome, defined as unstable angina or non-Q acute myocardial infarction, or ST-segment elevation ACS, defined as acute myocardial infarction, who completed the phase II outpatient cardiac rehabilitation program, attending at least 80% of the training sessions and all medical visits.

Exclusion criteria

Exclusion criteria: Patients who could not follow phase III for working reasons or declined to participate.

Design outcomes

Primary

Measure	Time frame
All patients underwent a specific evaluation before (taking the final specific tests and measurements of the phase II CRP) and post-intervention (at 12 months) of each of the following sections: 1. Functional capacity: Incremental exercise test (IET) was performed using the Bruce protocol on an endless treadmill, stopping due to fatigue or symptoms, following the standards defined by the Spanish Society of Cardiology (SEC). 2. Heart rate and blood pressure were measured at baseline, peak condition, and the maximum load in METs. 3. On separate days, the six-minute walk test (6MWT) was performed, following the protocol established by the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR). The maximum distance walked, the baseline and final heart rate, blood pressure, dyspnea and fatigue using the modified Borg Scale were registered.	—

Measure

Time frame

All patients underwent a specific evaluation before (taking the final specific tests and measurements of the phase II CRP) and post-intervention (at 12 months) of each of the following sections: 1. Functional capacity: Incremental exercise test (IET) was performed using the Bruce protocol on an endless treadmill, stopping due to fatigue or symptoms, following the standards defined by the Spanish Society of Cardiology (SEC). 2. Heart rate and blood pressure were measured at baseline, peak condition, and the maximum load in METs. 3. On separate days, the six-minute walk test (6MWT) was performed, following the protocol established by the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR). The maximum distance walked, the baseline and final heart rate, blood pressure, dyspnea and fatigue using the modified Borg Scale were registered.

—

Secondary

Measure	Time frame
1. Body composition: body weight and abdominal perimeter were measured. The body composition was carried out using electrical bioimpedance analysis (Bodystat 500, England), following the standards defined by the Spanish Kinanthropometry Group (GREC). 2. Level of daily physical activity: the International Physical Activity Questionnaire (IPAQ) extended version was applied, consisting of 27 questions related to physical activity at work, home and leisure levels, quantified in minutes/day or minutes/week. Additionally, were registered cardiological events that required hospital medical treatment and adherence to exercise, which was defined as performing 80% or more of the intervention as it was prescribed.	—

Measure

Time frame

1. Body composition: body weight and abdominal perimeter were measured. The body composition was carried out using electrical bioimpedance analysis (Bodystat 500, England), following the standards defined by the Spanish Kinanthropometry Group (GREC). 2. Level of daily physical activity: the International Physical Activity Questionnaire (IPAQ) extended version was applied, consisting of 27 questions related to physical activity at work, home and leisure levels, quantified in minutes/day or minutes/week. Additionally, were registered cardiological events that required hospital medical treatment and adherence to exercise, which was defined as performing 80% or more of the intervention as it was prescribed.

—

Countries

Spain

Contacts

Public ContactJordi Vilaró

jordivc@blanquerna.url.edu+34 932 53 32 56

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026